fanta.bio Sample: CNhs11886
25910 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| CTNNB1 SRX13991431 | MCF 10A Breast | 607 / 20289 (3.0%) | 177 / 202890 (0.1%) | −324.0 | −324.0 | 34.29 |
| SCML2 SRX644728 | 293 Kidney | 2040 / 20289 (10.1%) | 629 / 202890 (0.3%) | −324.0 | −324.0 | 32.43 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 2246 / 20289 (11.1%) | 722 / 202890 (0.4%) | −324.0 | −324.0 | 31.11 |
| FOXP1 SRX736067 | LNCAP Prostate | 2725 / 20289 (13.4%) | 961 / 202890 (0.5%) | −324.0 | −324.0 | 28.36 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 3121 / 20289 (15.4%) | 1115 / 202890 (0.5%) | −324.0 | −324.0 | 27.99 |
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 1288 / 20289 (6.3%) | 464 / 202890 (0.2%) | −324.0 | −324.0 | 27.76 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 3027 / 20289 (14.9%) | 1098 / 202890 (0.5%) | −324.0 | −324.0 | 27.57 |
| AR SRX10820653 | LNCAP Prostate | 473 / 20289 (2.3%) | 190 / 202890 (0.1%) | −324.0 | −324.0 | 24.89 |
| TP53 SRX19538274 | U2OS Bone | 476 / 20289 (2.3%) | 193 / 202890 (0.1%) | −324.0 | −324.0 | 24.66 |
| TP53 SRX19538268 | U2OS Bone | 476 / 20289 (2.3%) | 199 / 202890 (0.1%) | −324.0 | −324.0 | 23.92 |
| HIF1A SRX11007095 | HK-2 Kidney | 2386 / 20289 (11.8%) | 1083 / 202890 (0.5%) | −324.0 | −324.0 | 22.03 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1829 / 20289 (9.0%) | 869 / 202890 (0.4%) | −324.0 | −324.0 | 21.05 |
| MYH11 SRX265221 | ME-1 Blood | 1176 / 20289 (5.8%) | 605 / 202890 (0.3%) | −324.0 | −324.0 | 19.44 |
| HIF1A SRX20663235 | HK-2 Kidney | 579 / 20289 (2.9%) | 301 / 202890 (0.1%) | −324.0 | −324.0 | 19.24 |
| TP53 SRX19538279 | Osteoblasts Bone | 570 / 20289 (2.8%) | 330 / 202890 (0.2%) | −324.0 | −324.0 | 17.27 |
| MED1 SRX9419945 | BT-474 Breast | 4079 / 20289 (20.1%) | 3243 / 202890 (1.6%) | −324.0 | −324.0 | 12.58 |
| MED1 SRX9419944 | BT-474 Breast | 3948 / 20289 (19.5%) | 3205 / 202890 (1.6%) | −324.0 | −324.0 | 12.32 |
| MED1 SRX9419946 | BT-474 Breast | 4164 / 20289 (20.5%) | 3418 / 202890 (1.7%) | −324.0 | −324.0 | 12.18 |
| BRD4 SRX9419936 | BT-474 Breast | 4118 / 20289 (20.3%) | 3400 / 202890 (1.7%) | −324.0 | −324.0 | 12.11 |
| BRD4 SRX9419938 | BT-474 Breast | 4084 / 20289 (20.1%) | 3408 / 202890 (1.7%) | −324.0 | −324.0 | 11.98 |
| BRD4 SRX9419935 | BT-474 Breast | 3910 / 20289 (19.3%) | 3274 / 202890 (1.6%) | −324.0 | −324.0 | 11.94 |
| MED1 SRX9419947 | BT-474 Breast | 4014 / 20289 (19.8%) | 3370 / 202890 (1.7%) | −324.0 | −324.0 | 11.91 |
| BRD4 SRX9419937 | BT-474 Breast | 3918 / 20289 (19.3%) | 3319 / 202890 (1.6%) | −324.0 | −324.0 | 11.80 |
| EZH2 SRX2146136 | LNCAP Prostate | 9660 / 20289 (47.6%) | 8934 / 202890 (4.4%) | −324.0 | −324.0 | 10.81 |
| BRD4 SRX736201 | 90-8TL Neural | 7100 / 20289 (35.0%) | 7478 / 202890 (3.7%) | −324.0 | −324.0 | 9.49 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 857 / 20289 (4.2%) | 1029 / 202890 (0.5%) | −324.0 | −324.0 | 8.33 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 2380 / 20289 (11.7%) | 2968 / 202890 (1.5%) | −324.0 | −324.0 | 8.02 |
| MED1 SRX8807165 | MOLM-13 Blood | 1385 / 20289 (6.8%) | 2643 / 202890 (1.3%) | −324.0 | −324.0 | 5.24 |
| PAF1 SRX1873455 | SEM Blood | 1144 / 20289 (5.6%) | 2207 / 202890 (1.1%) | −324.0 | −324.0 | 5.18 |
| BRD4 SRX20304308 | NB-4 Blood | 1210 / 20289 (6.0%) | 2347 / 202890 (1.2%) | −324.0 | −324.0 | 5.16 |
| CHD1 SRX116417 | K-562 Blood | 1051 / 20289 (5.2%) | 2039 / 202890 (1.0%) | −324.0 | −324.0 | 5.15 |
| KMT2A SRX5668134 | IMS-M2 Blood | 1141 / 20289 (5.6%) | 2277 / 202890 (1.1%) | −324.0 | −324.0 | 5.01 |
| AFF1 SRX15203358 | Acute lymphoid leukemia Blood | 1233 / 20289 (6.1%) | 2462 / 202890 (1.2%) | −324.0 | −324.0 | 5.01 |
| CHD1 SRX186771 | K-562 Blood | 1125 / 20289 (5.5%) | 2259 / 202890 (1.1%) | −324.0 | −324.0 | 4.98 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 1918 / 20289 (9.5%) | 4163 / 202890 (2.1%) | −324.0 | −324.0 | 4.61 |
| KMT2B DRX059615 | HB1119 Blood | 1465 / 20289 (7.2%) | 3222 / 202890 (1.6%) | −324.0 | −324.0 | 4.55 |
| BRPF3 SRX796085 | RKO Digestive tract | 1807 / 20289 (8.9%) | 3992 / 202890 (2.0%) | −324.0 | −324.0 | 4.53 |
| KMT2B DRX059614 | HB1119 Blood | 1451 / 20289 (7.2%) | 3219 / 202890 (1.6%) | −324.0 | −324.0 | 4.51 |
| BRD1 SRX286203 | RKO Digestive tract | 2000 / 20289 (9.9%) | 4574 / 202890 (2.3%) | −324.0 | −324.0 | 4.37 |
| Epitope tags SRX10549778 | K-562 Blood | 1965 / 20289 (9.7%) | 4506 / 202890 (2.2%) | −324.0 | −324.0 | 4.36 |
| Epitope tags SRX10549776 | K-562 Blood | 2485 / 20289 (12.2%) | 5732 / 202890 (2.8%) | −324.0 | −324.0 | 4.34 |
| BRD4 SRX20304302 | NB-4 Blood | 1707 / 20289 (8.4%) | 3950 / 202890 (1.9%) | −324.0 | −324.0 | 4.32 |
| MEN1 SRX14030481 | MV-4-11 Blood | 1387 / 20289 (6.8%) | 3350 / 202890 (1.7%) | −324.0 | −324.0 | 4.14 |
| CDK9 SRX9730735 | THP-1 Blood | 1603 / 20289 (7.9%) | 3964 / 202890 (2.0%) | −324.0 | −324.0 | 4.04 |
| KAT7 SRX101303 | RKO Digestive tract | 2306 / 20289 (11.4%) | 5716 / 202890 (2.8%) | −324.0 | −324.0 | 4.03 |
| SETD1A SRX23734380 | MOLM-13 Blood | 1693 / 20289 (8.3%) | 4298 / 202890 (2.1%) | −324.0 | −324.0 | 3.94 |
| RBM22 SRX4708083 | K-562 Blood | 1384 / 20289 (6.8%) | 3526 / 202890 (1.7%) | −324.0 | −324.0 | 3.93 |
| MEN1 SRX14030471 | MV-4-11 Blood | 1522 / 20289 (7.5%) | 3903 / 202890 (1.9%) | −324.0 | −324.0 | 3.90 |
| LEO1 SRX1873456 | SEM Blood | 2615 / 20289 (12.9%) | 6727 / 202890 (3.3%) | −324.0 | −324.0 | 3.89 |
| AFF1 SRX2281250 | SEM Blood | 1455 / 20289 (7.2%) | 3805 / 202890 (1.9%) | −324.0 | −324.0 | 3.82 |
| SETD1A SRX23734394 | MOLM-13 Blood | 1610 / 20289 (7.9%) | 4247 / 202890 (2.1%) | −324.0 | −324.0 | 3.79 |
| EP300 ERX626821 | U-937 Blood | 2021 / 20289 (10.0%) | 5382 / 202890 (2.7%) | −324.0 | −324.0 | 3.76 |
| EP300 ERX626811 | U-937 Blood | 2015 / 20289 (9.9%) | 5371 / 202890 (2.6%) | −324.0 | −324.0 | 3.75 |
| SETD1A SRX23734379 | MOLM-13 Blood | 2035 / 20289 (10.0%) | 5472 / 202890 (2.7%) | −324.0 | −324.0 | 3.72 |
| KMT2A SRX14127515 | OCI-AML3 Blood | 1666 / 20289 (8.2%) | 4558 / 202890 (2.2%) | −324.0 | −324.0 | 3.66 |
| AGO2 SRX6783958 | Hep G2 Liver | 1814 / 20289 (8.9%) | 4964 / 202890 (2.4%) | −324.0 | −324.0 | 3.65 |
| ING5 SRX286202 | RKO Digestive tract | 2141 / 20289 (10.6%) | 5861 / 202890 (2.9%) | −324.0 | −324.0 | 3.65 |
| AGO2 SRX6783957 | Hep G2 Liver | 1832 / 20289 (9.0%) | 5050 / 202890 (2.5%) | −324.0 | −324.0 | 3.63 |
| BRPF3 SRX796084 | RKO Digestive tract | 2502 / 20289 (12.3%) | 6922 / 202890 (3.4%) | −324.0 | −324.0 | 3.61 |
| BRPF3 SRX796086 | RKO Digestive tract | 2357 / 20289 (11.6%) | 6550 / 202890 (3.2%) | −324.0 | −324.0 | 3.60 |
| DOT1L SRX12416059 | MV-4-11 Blood | 2054 / 20289 (10.1%) | 5961 / 202890 (2.9%) | −324.0 | −324.0 | 3.45 |
| KMT2A SRX14030476 | MV-4-11 Blood | 1694 / 20289 (8.3%) | 4936 / 202890 (2.4%) | −324.0 | −324.0 | 3.43 |
| Epitope tags SRX10715360 | HCB1 Blood | 1636 / 20289 (8.1%) | 4866 / 202890 (2.4%) | −324.0 | −324.0 | 3.36 |
| AFF1 SRX10484575 | RS4-11 Blood | 2402 / 20289 (11.8%) | 7180 / 202890 (3.5%) | −324.0 | −324.0 | 3.35 |
| MEN1 SRX11712604 | K-562 Blood | 2256 / 20289 (11.1%) | 6776 / 202890 (3.3%) | −324.0 | −324.0 | 3.33 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 1991 / 20289 (9.8%) | 6010 / 202890 (3.0%) | −324.0 | −324.0 | 3.31 |
| AGO2 SRX4708039 | Hep G2 Liver | 2774 / 20289 (13.7%) | 8499 / 202890 (4.2%) | −324.0 | −324.0 | 3.26 |
| Epitope tags SRX9252033 | MOLM-13 Blood | 2051 / 20289 (10.1%) | 6294 / 202890 (3.1%) | −324.0 | −324.0 | 3.26 |
| CXXC1 SRX1424886 | SEM Blood | 2278 / 20289 (11.2%) | 7025 / 202890 (3.5%) | −324.0 | −324.0 | 3.24 |
| Epitope tags DRX443510 | 293 Kidney | 2252 / 20289 (11.1%) | 6995 / 202890 (3.4%) | −324.0 | −324.0 | 3.22 |
| CDK9 SRX9730733 | THP-1 Blood | 2190 / 20289 (10.8%) | 6811 / 202890 (3.4%) | −324.0 | −324.0 | 3.22 |
| STAT1 SRX23678707 | K-562 Blood | 2201 / 20289 (10.8%) | 6910 / 202890 (3.4%) | −324.0 | −324.0 | 3.19 |
| KMT2A SRX14030485 | MV-4-11 Blood | 1946 / 20289 (9.6%) | 6138 / 202890 (3.0%) | −324.0 | −324.0 | 3.17 |
| MEAF6 DRX300417 | 293 Kidney | 2395 / 20289 (11.8%) | 7557 / 202890 (3.7%) | −324.0 | −324.0 | 3.17 |
| STAT1 SRX23678708 | K-562 Blood | 2377 / 20289 (11.7%) | 7550 / 202890 (3.7%) | −324.0 | −324.0 | 3.15 |
| BRD4 SRX8272937 | BLaER1 Blood | 1907 / 20289 (9.4%) | 6182 / 202890 (3.0%) | −324.0 | −324.0 | 3.08 |
| KMT2A SRX2281247 | SEM Blood | 2605 / 20289 (12.8%) | 8473 / 202890 (4.2%) | −324.0 | −324.0 | 3.07 |
| BRD4 SRX849382 | MOLM-14 Blood | 1851 / 20289 (9.1%) | 6022 / 202890 (3.0%) | −324.0 | −324.0 | 3.07 |
| MED1 SRX4937338 | HCT 116 Digestive tract | 2081 / 20289 (10.3%) | 6883 / 202890 (3.4%) | −324.0 | −324.0 | 3.02 |
| ING2 SRX286201 | RKO Digestive tract | 2072 / 20289 (10.2%) | 6856 / 202890 (3.4%) | −324.0 | −324.0 | 3.02 |
| MEAF6 DRX234811 | 293 Kidney | 2582 / 20289 (12.7%) | 8549 / 202890 (4.2%) | −324.0 | −324.0 | 3.02 |
| KMT2A SRX20870810 | SEM Blood | 2397 / 20289 (11.8%) | 7961 / 202890 (3.9%) | −324.0 | −324.0 | 3.01 |
| KMT2A SRX5732680 | MOLM-13 Blood | 1935 / 20289 (9.5%) | 6439 / 202890 (3.2%) | −324.0 | −324.0 | 3.01 |
| MED1 SRX4937342 | HCT 116 Digestive tract | 1919 / 20289 (9.5%) | 6394 / 202890 (3.2%) | −324.0 | −324.0 | 3.00 |
| JADE3 DRX300415 | 293 Kidney | 2251 / 20289 (11.1%) | 7610 / 202890 (3.8%) | −324.0 | −324.0 | 2.96 |
| BRD4 SRX3591438 | B-CLL cells Blood | 2010 / 20289 (9.9%) | 6968 / 202890 (3.4%) | −324.0 | −324.0 | 2.88 |
| RBBP5 SRX186645 | K-562 Blood | 2044 / 20289 (10.1%) | 7148 / 202890 (3.5%) | −324.0 | −324.0 | 2.86 |
| BRD4 SRX3591435 | B-CLL cells Blood | 2086 / 20289 (10.3%) | 7316 / 202890 (3.6%) | −324.0 | −324.0 | 2.85 |
| GATA1 SRX4172744 | HCT 116 Digestive tract | 2208 / 20289 (10.9%) | 7767 / 202890 (3.8%) | −324.0 | −324.0 | 2.84 |
| Epitope tags SRX1813533 | MV-4-11 Blood | 2577 / 20289 (12.7%) | 9131 / 202890 (4.5%) | −324.0 | −324.0 | 2.82 |
| HDAC1 SRX17989500 | PBMC Blood | 2320 / 20289 (11.4%) | 8221 / 202890 (4.1%) | −324.0 | −324.0 | 2.82 |
| KMT2A SRX14030475 | MV-4-11 Blood | 2313 / 20289 (11.4%) | 8354 / 202890 (4.1%) | −324.0 | −324.0 | 2.77 |
| BRD4 SRX3591434 | B-CLL cells Blood | 2151 / 20289 (10.6%) | 7790 / 202890 (3.8%) | −324.0 | −324.0 | 2.76 |
| RBFOX2 SRX3322782 | K-562 Blood | 2903 / 20289 (14.3%) | 10581 / 202890 (5.2%) | −324.0 | −324.0 | 2.74 |
| BCOR SRX10184500 | Acute myeloid leukemia Blood | 2352 / 20289 (11.6%) | 8603 / 202890 (4.2%) | −324.0 | −324.0 | 2.73 |
| MED1 SRX4937336 | HCT 116 Digestive tract | 2238 / 20289 (11.0%) | 8253 / 202890 (4.1%) | −324.0 | −324.0 | 2.71 |
| CPSF3L SRX9730737 | THP-1 Blood | 2251 / 20289 (11.1%) | 8413 / 202890 (4.1%) | −324.0 | −324.0 | 2.68 |
| RBFOX2 SRX3322781 | K-562 Blood | 3059 / 20289 (15.1%) | 11439 / 202890 (5.6%) | −324.0 | −324.0 | 2.67 |
| ZNF384 SRX17159338 | JIH-5 Blood | 2798 / 20289 (13.8%) | 10776 / 202890 (5.3%) | −324.0 | −324.0 | 2.60 |
| RBFOX2 SRX4708082 | K-562 Blood | 3693 / 20289 (18.2%) | 14267 / 202890 (7.0%) | −324.0 | −324.0 | 2.59 |
| RAG2 SRX1046558 | Thymus Blood | 2980 / 20289 (14.7%) | 11653 / 202890 (5.7%) | −324.0 | −324.0 | 2.56 |
| KMT2A SRX2281249 | SEM Blood | 2685 / 20289 (13.2%) | 11062 / 202890 (5.5%) | −324.0 | −324.0 | 2.43 |
| Epitope tags SRX10549777 | K-562 Blood | 3673 / 20289 (18.1%) | 15151 / 202890 (7.5%) | −324.0 | −324.0 | 2.42 |
| HDAC1 SRX17989501 | PBMC Blood | 2893 / 20289 (14.3%) | 12052 / 202890 (5.9%) | −324.0 | −324.0 | 2.40 |
| KMT2A SRX10484574 | RS4-11 Blood | 3004 / 20289 (14.8%) | 13045 / 202890 (6.4%) | −324.0 | −324.0 | 2.30 |
| KDM2B SRX1873447 | SEM Blood | 3393 / 20289 (16.7%) | 15141 / 202890 (7.5%) | −324.0 | −324.0 | 2.24 |
| PBX4 SRX2731658 | PC-3 Prostate | 1145 / 20289 (5.6%) | 32067 / 202890 (15.8%) | −324.0 | −324.0 | 0.36 |
| YAP1 SRX757325 | H2052 Lung | 806 / 20289 (4.0%) | 24898 / 202890 (12.3%) | −324.0 | −324.0 | 0.32 |
| YAP1 SRX757326 | H2052 Lung | 648 / 20289 (3.2%) | 22255 / 202890 (11.0%) | −324.0 | −324.0 | 0.29 |
| MED1 SRX4937340 | HCT 116 Digestive tract | 2233 / 20289 (11.0%) | 8386 / 202890 (4.1%) | −322.7 | −320.2 | 2.66 |
| SETD1A SRX23734395 | MOLM-13 Blood | 1280 / 20289 (6.3%) | 3108 / 202890 (1.5%) | −322.5 | −320.0 | 4.12 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 790 / 20289 (3.9%) | 1071 / 202890 (0.5%) | −322.4 | −319.9 | 7.38 |
| CDK9 SRX10131663 | Bronchial tracheal epithelial cells Lung | 1569 / 20289 (7.7%) | 4573 / 202890 (2.3%) | −321.8 | −319.3 | 3.43 |
| RBBP5 SRX116442 | K-562 Blood | 2024 / 20289 (10.0%) | 7170 / 202890 (3.5%) | −319.4 | −316.9 | 2.82 |
| ERG SRX682375 | TSU-1621MT Blood | 2523 / 20289 (12.4%) | 10266 / 202890 (5.1%) | −319.3 | −316.9 | 2.46 |
| SUPT5H SRX13440060 | MOLM-13 Blood | 2050 / 20289 (10.1%) | 7357 / 202890 (3.6%) | −317.2 | −314.7 | 2.79 |
| JADE3 DRX234809 | 293 Kidney | 1483 / 20289 (7.3%) | 4177 / 202890 (2.1%) | −316.8 | −314.3 | 3.55 |
| BRD2 SRX10760645 | MM.1S Blood | 2575 / 20289 (12.7%) | 10666 / 202890 (5.3%) | −315.9 | −313.5 | 2.41 |
| SUPT5H SRX13440061 | MOLM-13 Blood | 1925 / 20289 (9.5%) | 6641 / 202890 (3.3%) | −315.5 | −313.1 | 2.90 |
| TP53 SRX19538276 | U2OS Bone | 468 / 20289 (2.3%) | 215 / 202890 (0.1%) | −314.9 | −312.5 | 21.77 |
| KMT2A SRX14030478 | MV-4-11 Blood | 1246 / 20289 (6.1%) | 3016 / 202890 (1.5%) | −314.7 | −312.3 | 4.13 |
| FOS SRX150477 | MCF 10A Breast | 808 / 20289 (4.0%) | 23938 / 202890 (11.8%) | −314.7 | −312.2 | 0.34 |
| KMT2A SRX14127517 | OCI-AML3 Blood | 1872 / 20289 (9.2%) | 6348 / 202890 (3.1%) | −314.3 | −311.9 | 2.95 |
| NELFE SRX23734382 | MOLM-13 Blood | 2129 / 20289 (10.5%) | 7885 / 202890 (3.9%) | −313.7 | −311.3 | 2.70 |
| KAT7 DRX234808 | 293 Kidney | 1144 / 20289 (5.6%) | 2557 / 202890 (1.3%) | −312.9 | −310.5 | 4.47 |
| TP53 SRX19538267 | U2OS Bone | 441 / 20289 (2.2%) | 172 / 202890 (0.1%) | −311.6 | −309.1 | 25.64 |
| BRD4 SRX9730741 | THP-1 Blood | 3180 / 20289 (15.7%) | 14875 / 202890 (7.3%) | −310.3 | −307.9 | 2.14 |
| FOS SRX19553531 | Kasumi-1 Blood | 2152 / 20289 (10.6%) | 8089 / 202890 (4.0%) | −309.7 | −307.3 | 2.66 |
| KMT2A SRX15203357 | Acute lymphoid leukemia Blood | 2374 / 20289 (11.7%) | 9483 / 202890 (4.7%) | −309.4 | −307.0 | 2.50 |
| ESR1 SRX2897220 | Breast cancer cells Breast | 2144 / 20289 (10.6%) | 8054 / 202890 (4.0%) | −308.7 | −306.3 | 2.66 |
| Epitope tags SRX12416065 | MOLM-13 Blood | 691 / 20289 (3.4%) | 810 / 202890 (0.4%) | −308.6 | −306.2 | 8.53 |
| KMT2A SRX15213704 | SEM Blood | 2595 / 20289 (12.8%) | 10933 / 202890 (5.4%) | −308.4 | −306.0 | 2.37 |
| BRD2 SRX7061817 | SEM Blood | 3017 / 20289 (14.9%) | 13804 / 202890 (6.8%) | −307.2 | −304.8 | 2.19 |
| KMT2A SRX20870812 | SEM Blood | 1606 / 20289 (7.9%) | 4948 / 202890 (2.4%) | −306.7 | −304.3 | 3.25 |
| RUNX1 SRX2513054 | 293 Kidney | 4009 / 20289 (19.8%) | 21010 / 202890 (10.4%) | −305.8 | −303.4 | 1.91 |
| BRD4 SRX3591437 | B-CLL cells Blood | 1989 / 20289 (9.8%) | 7162 / 202890 (3.5%) | −305.6 | −303.2 | 2.78 |
| TAF1 SRX11120885 | MCF-7 Breast | 2318 / 20289 (11.4%) | 9194 / 202890 (4.5%) | −305.5 | −303.1 | 2.52 |
| KMT2A SRX1424881 | SEM Blood | 1584 / 20289 (7.8%) | 4849 / 202890 (2.4%) | −305.0 | −302.6 | 3.27 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 1262 / 20289 (6.2%) | 3207 / 202890 (1.6%) | −302.4 | −300.1 | 3.94 |
| BRD3 SRX6913042 | THP-1 Blood | 1539 / 20289 (7.6%) | 4640 / 202890 (2.3%) | −302.0 | −299.6 | 3.32 |
| FOS SRX150478 | MCF 10A Breast | 875 / 20289 (4.3%) | 24519 / 202890 (12.1%) | −301.0 | −298.6 | 0.36 |
| CPSF3L SRX3345950 | HL-60 Blood | 1570 / 20289 (7.7%) | 4823 / 202890 (2.4%) | −300.8 | −298.4 | 3.26 |
| TCF12 SRX265225 | ME-1 Blood | 1655 / 20289 (8.2%) | 5307 / 202890 (2.6%) | −299.6 | −297.3 | 3.12 |
| BRD4 SRX736204 | 90-8TL Neural | 1278 / 20289 (6.3%) | 3317 / 202890 (1.6%) | −299.2 | −296.9 | 3.85 |
| NELFE SRX23734381 | MOLM-13 Blood | 1733 / 20289 (8.5%) | 5760 / 202890 (2.8%) | −298.6 | −296.2 | 3.01 |
| ZNF711 SRX7805363 | 293 Kidney | 2098 / 20289 (10.3%) | 7938 / 202890 (3.9%) | −298.2 | −295.9 | 2.64 |
| Crotonyllysine SRX19488269 | GSC23 Neural | 1685 / 20289 (8.3%) | 5500 / 202890 (2.7%) | −297.7 | −295.4 | 3.06 |
| BRD4 SRX6913048 | THP-1 Blood | 2000 / 20289 (9.9%) | 7351 / 202890 (3.6%) | −297.4 | −295.1 | 2.72 |
| KMT2A SRX14030486 | MV-4-11 Blood | 1674 / 20289 (8.3%) | 5443 / 202890 (2.7%) | −297.3 | −295.0 | 3.08 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 770 / 20289 (3.8%) | 1136 / 202890 (0.6%) | −296.4 | −294.1 | 6.78 |
| ERG SRX265230 | ME-1 Blood | 2878 / 20289 (14.2%) | 13106 / 202890 (6.5%) | −294.7 | −292.4 | 2.20 |
| ETS1 SRX9046311 | THP-1 Blood | 1546 / 20289 (7.6%) | 4781 / 202890 (2.4%) | −293.4 | −291.0 | 3.23 |
| BRD4 SRX3591431 | B-CLL cells Blood | 1950 / 20289 (9.6%) | 7118 / 202890 (3.5%) | −292.9 | −290.5 | 2.74 |
| NELFE SRX13440062 | MOLM-13 Blood | 2151 / 20289 (10.6%) | 8366 / 202890 (4.1%) | −292.1 | −289.8 | 2.57 |
| RUNX1 SRX265222 | ME-1 Blood | 1850 / 20289 (9.1%) | 6546 / 202890 (3.2%) | −291.0 | −288.7 | 2.83 |
| TP53 SRX19538275 | U2OS Bone | 432 / 20289 (2.1%) | 198 / 202890 (0.1%) | −290.9 | −288.5 | 21.82 |
| BCOR SRX10184504 | OCI-AML3 Blood | 2175 / 20289 (10.7%) | 8552 / 202890 (4.2%) | −289.8 | −287.5 | 2.54 |
| KDM4C SRX424010 | KYSE-150 Digestive tract | 1697 / 20289 (8.4%) | 5675 / 202890 (2.8%) | −289.5 | −287.2 | 2.99 |
| KMT2A SRX15203354 | Acute lymphoid leukemia Blood | 1627 / 20289 (8.0%) | 5280 / 202890 (2.6%) | −289.4 | −287.1 | 3.08 |
| TP53 SRX19538281 | Osteoblasts Bone | 494 / 20289 (2.4%) | 335 / 202890 (0.2%) | −289.0 | −286.7 | 14.75 |
| AFF1 SRX4931279 | SEM Blood | 869 / 20289 (4.3%) | 1560 / 202890 (0.8%) | −288.4 | −286.0 | 5.57 |
| MEN1 SRX11712606 | K-562 Blood | 1234 / 20289 (6.1%) | 3212 / 202890 (1.6%) | −287.7 | −285.4 | 3.84 |
| AR SRX10820651 | LNCAP Prostate | 485 / 20289 (2.4%) | 318 / 202890 (0.2%) | −287.6 | −285.3 | 15.25 |
| HDAC1 SRX20517420 | Keratinocytes Epidermis | 2246 / 20289 (11.1%) | 9045 / 202890 (4.5%) | −287.5 | −285.2 | 2.48 |
| SUPT5H SRX2314263 | MOLT-4 Blood | 2266 / 20289 (11.2%) | 9177 / 202890 (4.5%) | −287.2 | −284.9 | 2.47 |
| BMI1 SRX644729 | 293 Kidney | 375 / 20289 (1.8%) | 108 / 202890 (0.1%) | −286.2 | −283.9 | 34.72 |
| KMT2A SRX14030477 | MV-4-11 Blood | 1158 / 20289 (5.7%) | 2864 / 202890 (1.4%) | −285.3 | −283.0 | 4.04 |
| TP53 SRX396254 | Fibroblasts Others | 1200 / 20289 (5.9%) | 3069 / 202890 (1.5%) | −285.2 | −282.9 | 3.91 |
| FLI1 SRX026640 | SKNO-1 Blood | 3067 / 20289 (15.1%) | 14631 / 202890 (7.2%) | −285.2 | −282.9 | 2.10 |
| KMT2A SRX15203360 | Acute lymphoid leukemia Blood | 3135 / 20289 (15.5%) | 15124 / 202890 (7.5%) | −284.8 | −282.5 | 2.07 |
| FLI1 SRX117011 | U-937 Blood | 1911 / 20289 (9.4%) | 7017 / 202890 (3.5%) | −284.0 | −281.7 | 2.72 |
| RBFOX2 SRX4708034 | Hep G2 Liver | 2515 / 20289 (12.4%) | 10868 / 202890 (5.4%) | −283.7 | −281.4 | 2.31 |
| TP53 SRX19538280 | Osteoblasts Bone | 447 / 20289 (2.2%) | 245 / 202890 (0.1%) | −283.5 | −281.3 | 18.24 |
| MYC SRX13134693 | 293 Kidney | 1789 / 20289 (8.8%) | 6294 / 202890 (3.1%) | −283.5 | −281.3 | 2.84 |
| TP53 SRX19538273 | U2OS Bone | 416 / 20289 (2.1%) | 186 / 202890 (0.1%) | −282.3 | −280.0 | 22.37 |
| GATA1 SRX097108 | K-562 Blood | 2074 / 20289 (10.2%) | 8053 / 202890 (4.0%) | −281.9 | −279.6 | 2.58 |
| INTS13 SRX3934085 | HL-60 Blood | 2028 / 20289 (10.0%) | 7765 / 202890 (3.8%) | −281.8 | −279.6 | 2.61 |
| ESR1 SRX2897217 | Breast cancer cells Breast | 1362 / 20289 (6.7%) | 3928 / 202890 (1.9%) | −281.8 | −279.5 | 3.47 |
| BRD3 SRX7061818 | SEM Blood | 1243 / 20289 (6.1%) | 3320 / 202890 (1.6%) | −281.4 | −279.1 | 3.74 |
| ZNF711 SRX7805362 | 293 Kidney | 1965 / 20289 (9.7%) | 7390 / 202890 (3.6%) | −281.1 | −278.9 | 2.66 |
| KMT2A SRX15213698 | SEM Blood | 1776 / 20289 (8.8%) | 6259 / 202890 (3.1%) | −280.5 | −278.3 | 2.84 |
| RUNX1 SRX23677919 | MOLM-14 Blood | 1871 / 20289 (9.2%) | 6829 / 202890 (3.4%) | −280.5 | −278.2 | 2.74 |
| MED1 SRX1873451 | SEM Blood | 2813 / 20289 (13.9%) | 12971 / 202890 (6.4%) | −279.8 | −277.6 | 2.17 |
| BRD2 SRX6913057 | THP-1 Blood | 2184 / 20289 (10.8%) | 8804 / 202890 (4.3%) | −278.6 | −276.3 | 2.48 |
| RARA SRX682379 | TSU-1621MT Blood | 1561 / 20289 (7.7%) | 5079 / 202890 (2.5%) | −276.3 | −274.0 | 3.07 |
| KDM5A SRX23740431 | SUM 149PT Breast | 1974 / 20289 (9.7%) | 7538 / 202890 (3.7%) | −275.3 | −273.1 | 2.62 |
| FLI1 SRX117010 | U-937 Blood | 1669 / 20289 (8.2%) | 5710 / 202890 (2.8%) | −275.2 | −273.0 | 2.92 |
| BRD4 SRX6913062 | THP-1 Blood | 1441 / 20289 (7.1%) | 4440 / 202890 (2.2%) | −274.1 | −271.9 | 3.25 |
| BRD4 SRX8272901 | BLaER1 Blood | 1139 / 20289 (5.6%) | 2885 / 202890 (1.4%) | −273.3 | −271.1 | 3.95 |
| RUNX1 SRX23677920 | MOLM-14 Blood | 2072 / 20289 (10.2%) | 8183 / 202890 (4.0%) | −273.3 | −271.1 | 2.53 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 1119 / 20289 (5.5%) | 2798 / 202890 (1.4%) | −272.2 | −270.0 | 4.00 |
| PHF8 SRX186646 | K-562 Blood | 2508 / 20289 (12.4%) | 11054 / 202890 (5.4%) | −271.9 | −269.6 | 2.27 |
| AFF1 SRX9560790 | Spleen Others | 801 / 20289 (3.9%) | 1398 / 202890 (0.7%) | −271.7 | −269.5 | 5.73 |
| BRD4 SRX6913050 | THP-1 Blood | 1549 / 20289 (7.6%) | 5071 / 202890 (2.5%) | −271.6 | −269.4 | 3.05 |
| XPO1 SRX14127501 | OCI-AML3 Blood | 742 / 20289 (3.7%) | 1175 / 202890 (0.6%) | −271.2 | −269.0 | 6.31 |
| ZFX SRX3322295 | HCT 116 Digestive tract | 1793 / 20289 (8.8%) | 6504 / 202890 (3.2%) | −270.9 | −268.6 | 2.76 |
| LEO1 SRX15147190 | DLD-1 Digestive tract | 1196 / 20289 (5.9%) | 3191 / 202890 (1.6%) | −270.9 | −268.6 | 3.75 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 2556 / 20289 (12.6%) | 11406 / 202890 (5.6%) | −270.4 | −268.2 | 2.24 |
| STAT1 SRX2961561 | SET-2 Blood | 2593 / 20289 (12.8%) | 11673 / 202890 (5.8%) | −269.7 | −267.5 | 2.22 |
| BAHCC1 SRX8449940 | Jurkat Blood | 2968 / 20289 (14.6%) | 14288 / 202890 (7.0%) | −269.4 | −267.2 | 2.08 |
| HDAC1 SRX17989497 | PBMC Blood | 2369 / 20289 (11.7%) | 10192 / 202890 (5.0%) | −268.5 | −266.3 | 2.32 |
| BRD4 SRX12129503 | T cells Blood | 1545 / 20289 (7.6%) | 5095 / 202890 (2.5%) | −268.1 | −265.9 | 3.03 |
| RUNX1 SRX1514291 | Kasumi-1 Blood | 1892 / 20289 (9.3%) | 7150 / 202890 (3.5%) | −267.9 | −265.7 | 2.65 |
| ZFX SRX3091912 | HCT 116 Digestive tract | 1781 / 20289 (8.8%) | 6479 / 202890 (3.2%) | −267.8 | −265.6 | 2.75 |
| GFP SRX20436833 | DLD-1 Digestive tract | 1958 / 20289 (9.7%) | 7565 / 202890 (3.7%) | −267.5 | −265.3 | 2.59 |
| Epitope tags SRX23734393 | MOLM-13 Blood | 765 / 20289 (3.8%) | 1284 / 202890 (0.6%) | −267.5 | −265.3 | 5.96 |
| KMT2A SRX1293531 | MV-4-11 Blood | 3219 / 20289 (15.9%) | 16136 / 202890 (8.0%) | −267.5 | −265.3 | 1.99 |
| RUNX1 SRX23677917 | MOLM-14 Blood | 1993 / 20289 (9.8%) | 7795 / 202890 (3.8%) | −266.8 | −264.6 | 2.56 |
| TAF1 SRX11120886 | MCF-7 Breast | 2389 / 20289 (11.8%) | 10388 / 202890 (5.1%) | −265.1 | −262.9 | 2.30 |
| Epitope tags SRX10657969 | NALM-6 Blood | 2576 / 20289 (12.7%) | 11668 / 202890 (5.8%) | −264.2 | −262.0 | 2.21 |
| CTCF SRX10976008 | NALM-6 Blood | 3227 / 20289 (15.9%) | 16292 / 202890 (8.0%) | −263.5 | −261.3 | 1.98 |
| DOT1L SRX12416060 | MV-4-11 Blood | 830 / 20289 (4.1%) | 1570 / 202890 (0.8%) | −263.4 | −261.2 | 5.29 |
| FOS SRX4192880 | MCF 10A Breast | 632 / 20289 (3.1%) | 19444 / 202890 (9.6%) | −263.0 | −260.8 | 0.33 |
| ERG SRX063922 | K-562 Blood | 2026 / 20289 (10.0%) | 8076 / 202890 (4.0%) | −262.5 | −260.3 | 2.51 |
| MECOM SRX23677885 | HNT-34 Blood | 2238 / 20289 (11.0%) | 9447 / 202890 (4.7%) | −262.2 | −260.0 | 2.37 |
| BRPF1 SRX10606575 | GIST-T1 Digestive tract | 913 / 20289 (4.5%) | 1942 / 202890 (1.0%) | −260.9 | −258.8 | 4.70 |
| MEN1 SRX14030484 | MV-4-11 Blood | 945 / 20289 (4.7%) | 2090 / 202890 (1.0%) | −260.3 | −258.1 | 4.52 |
| ZFX SRX7805365 | 22Rv1 Prostate | 1790 / 20289 (8.8%) | 6652 / 202890 (3.3%) | −260.0 | −257.8 | 2.69 |
| KMT2A SRX9560789 | Spleen Others | 1811 / 20289 (8.9%) | 6783 / 202890 (3.3%) | −259.8 | −257.6 | 2.67 |
| TAF3 SRX217738 | HCT 116 Digestive tract | 1660 / 20289 (8.2%) | 5875 / 202890 (2.9%) | −259.8 | −257.6 | 2.83 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 1746 / 20289 (8.6%) | 6396 / 202890 (3.2%) | −259.3 | −257.2 | 2.73 |
| RBFOX2 SRX3323050 | Hep G2 Liver | 2019 / 20289 (10.0%) | 8094 / 202890 (4.0%) | −258.8 | −256.6 | 2.49 |
| KMT2A SRX2323891 | 293 Kidney | 1305 / 20289 (6.4%) | 3889 / 202890 (1.9%) | −258.6 | −256.5 | 3.36 |
| ERG SRX026639 | SKNO-1 Blood | 2862 / 20289 (14.1%) | 13784 / 202890 (6.8%) | −258.6 | −256.4 | 2.08 |
| KMT2A SRX15213696 | SEM Blood | 1517 / 20289 (7.5%) | 5063 / 202890 (2.5%) | −258.5 | −256.4 | 3.00 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 1040 / 20289 (5.1%) | 2547 / 202890 (1.3%) | −258.4 | −256.2 | 4.08 |
| CTCF SRX10976002 | NALM-6 Blood | 3676 / 20289 (18.1%) | 19775 / 202890 (9.7%) | −257.9 | −255.7 | 1.86 |
| CIC SRX13262055 | Astrocytes Neural | 3676 / 20289 (18.1%) | 19796 / 202890 (9.8%) | −257.1 | −255.0 | 1.86 |
| BRD4 SRX3591429 | B-CLL cells Blood | 1296 / 20289 (6.4%) | 3868 / 202890 (1.9%) | −256.3 | −254.1 | 3.35 |
| MYC SRX10338563 | NALM-6 Blood | 2238 / 20289 (11.0%) | 9564 / 202890 (4.7%) | −256.0 | −253.8 | 2.34 |
| Epitope tags SRX8030771 | 293 Kidney | 2094 / 20289 (10.3%) | 8632 / 202890 (4.3%) | −255.6 | −253.5 | 2.43 |
| CTCF SRX10976000 | NALM-6 Blood | 3639 / 20289 (17.9%) | 19561 / 202890 (9.6%) | −255.4 | −253.3 | 1.86 |
| KAT6A DRX366109 | 293 Kidney | 2635 / 20289 (13.0%) | 12273 / 202890 (6.0%) | −255.0 | −252.8 | 2.15 |
| GATA2 SRX4393709 | ME-1 Blood | 2365 / 20289 (11.7%) | 10433 / 202890 (5.1%) | −254.7 | −252.6 | 2.27 |
| ZNF384 SRX17159337 | JIH-5 Blood | 2053 / 20289 (10.1%) | 8383 / 202890 (4.1%) | −254.7 | −252.6 | 2.45 |
| PSIP1 SRX1293534 | MV-4-11 Blood | 1206 / 20289 (5.9%) | 3413 / 202890 (1.7%) | −254.6 | −252.4 | 3.53 |
| CTCF SRX10975999 | NALM-6 Blood | 3939 / 20289 (19.4%) | 21883 / 202890 (10.8%) | −254.6 | −252.4 | 1.80 |
| SUPT5H SRX2314264 | MOLT-4 Blood | 2098 / 20289 (10.3%) | 8678 / 202890 (4.3%) | −254.4 | −252.3 | 2.42 |
| GATA2 SRX4393708 | ME-1 Blood | 1870 / 20289 (9.2%) | 7235 / 202890 (3.6%) | −254.3 | −252.2 | 2.58 |
| TP53 SRX19538269 | U2OS Bone | 515 / 20289 (2.5%) | 508 / 202890 (0.3%) | −253.1 | −250.9 | 10.14 |
| BCORL1 SRX10184496 | K-562 Blood | 2545 / 20289 (12.5%) | 11704 / 202890 (5.8%) | −252.4 | −250.3 | 2.17 |
| AFF1 SRX4931281 | SEM Blood | 746 / 20289 (3.7%) | 1306 / 202890 (0.6%) | −252.2 | −250.1 | 5.71 |
| CTCF SRX12008351 | MCF 10A Breast | 3627 / 20289 (17.9%) | 19562 / 202890 (9.6%) | −252.2 | −250.1 | 1.85 |
| FOXO1 SRX1735651 | Pre-leukemia stem cells Blood | 2150 / 20289 (10.6%) | 9060 / 202890 (4.5%) | −252.1 | −249.9 | 2.37 |
| BRD4 SRX1287854 | MOLM-14 Blood | 1769 / 20289 (8.7%) | 6652 / 202890 (3.3%) | −251.8 | −249.7 | 2.66 |
| PHF8 SRX116436 | K-562 Blood | 2011 / 20289 (9.9%) | 8171 / 202890 (4.0%) | −251.5 | −249.3 | 2.46 |
| BRD4 SRX7061826 | SEM Blood | 1493 / 20289 (7.4%) | 5024 / 202890 (2.5%) | −251.2 | −249.1 | 2.97 |
| BRD4 SRX9071237 | SEM Blood | 1493 / 20289 (7.4%) | 5024 / 202890 (2.5%) | −251.2 | −249.1 | 2.97 |
| BCOR SRX10184493 | K-562 Blood | 2733 / 20289 (13.5%) | 13050 / 202890 (6.4%) | −250.8 | −248.7 | 2.09 |
| RBFOX2 SRX3323051 | Hep G2 Liver | 1945 / 20289 (9.6%) | 7767 / 202890 (3.8%) | −250.6 | −248.5 | 2.50 |
| Epitope tags SRX10715405 | HCB1 Blood | 761 / 20289 (3.8%) | 1385 / 202890 (0.7%) | −249.3 | −247.2 | 5.49 |
| MECOM SRX23677884 | HNT-34 Blood | 2178 / 20289 (10.7%) | 9300 / 202890 (4.6%) | −249.1 | −247.0 | 2.34 |
| KMT2A SRX10269617 | MV-4-11 Blood | 614 / 20289 (3.0%) | 838 / 202890 (0.4%) | −248.9 | −246.8 | 7.33 |
| DNA-RNA hybrid SRX20083264 | SH-SY5Y Neural | 989 / 20289 (4.9%) | 2391 / 202890 (1.2%) | −248.9 | −246.8 | 4.14 |
| JMJD6 SRX2270409 | Tumor Others | 1815 / 20289 (8.9%) | 6983 / 202890 (3.4%) | −248.8 | −246.7 | 2.60 |
| ERG SRX063921 | K-562 Blood | 1906 / 20289 (9.4%) | 7578 / 202890 (3.7%) | −247.1 | −245.0 | 2.52 |
| BRD2 SRX6913055 | THP-1 Blood | 1843 / 20289 (9.1%) | 7184 / 202890 (3.5%) | −247.0 | −244.9 | 2.57 |
| BCOR SRX10184505 | KG-1 Blood | 1260 / 20289 (6.2%) | 3784 / 202890 (1.9%) | −247.0 | −244.9 | 3.33 |
| KMT2A SRX8151120 | VDH-15 Others | 2630 / 20289 (13.0%) | 12414 / 202890 (6.1%) | −247.0 | −244.9 | 2.12 |
| BRD2 SRX10760646 | MM.1S Blood | 2268 / 20289 (11.2%) | 9955 / 202890 (4.9%) | −246.1 | −244.0 | 2.28 |
| PAF1 SRX12416063 | MV-4-11 Blood | 1124 / 20289 (5.5%) | 3089 / 202890 (1.5%) | −245.5 | −243.4 | 3.64 |
| FOS SRX150517 | MCF 10A Breast | 667 / 20289 (3.3%) | 19405 / 202890 (9.6%) | −245.3 | −243.2 | 0.34 |
| SUPT6H SRX15147167 | DLD-1 Digestive tract | 1694 / 20289 (8.3%) | 6297 / 202890 (3.1%) | −245.3 | −243.2 | 2.69 |
| MEAF6 SRX10606585 | GIST-T1 Digestive tract | 2167 / 20289 (10.7%) | 9303 / 202890 (4.6%) | −245.1 | −243.0 | 2.33 |
| PAF1 SRX12416064 | MV-4-11 Blood | 1259 / 20289 (6.2%) | 3804 / 202890 (1.9%) | −244.8 | −242.7 | 3.31 |
| CTCF SRX10976007 | NALM-6 Blood | 3238 / 20289 (16.0%) | 16850 / 202890 (8.3%) | −244.6 | −242.5 | 1.92 |
| BRD2 SRX6913054 | THP-1 Blood | 2326 / 20289 (11.5%) | 10384 / 202890 (5.1%) | −244.1 | −242.0 | 2.24 |
| KAT6A DRX366108 | 293 Kidney | 2188 / 20289 (10.8%) | 9467 / 202890 (4.7%) | −243.8 | −241.8 | 2.31 |
| ETV6 SRX11661399 | EW-8 Bone | 2424 / 20289 (11.9%) | 11079 / 202890 (5.5%) | −242.8 | −240.8 | 2.19 |
| CTCF SRX12008350 | MCF 10A Breast | 3688 / 20289 (18.2%) | 20299 / 202890 (10.0%) | −242.5 | −240.4 | 1.82 |
| HDAC1 SRX20517422 | Keratinocytes Epidermis | 1755 / 20289 (8.7%) | 6716 / 202890 (3.3%) | −242.4 | −240.3 | 2.61 |
| LARP7 SRX2198835 | HeLa Uterus | 2637 / 20289 (13.0%) | 12574 / 202890 (6.2%) | −242.0 | −240.0 | 2.10 |
| MBD3 SRX1674506 | HeLa Uterus | 3249 / 20289 (16.0%) | 17002 / 202890 (8.4%) | −242.0 | −239.9 | 1.91 |
| INTS3 SRX3640569 | HeLa Uterus | 1631 / 20289 (8.0%) | 5970 / 202890 (2.9%) | −241.8 | −239.7 | 2.73 |
| BRD4 SRX6913045 | THP-1 Blood | 1557 / 20289 (7.7%) | 5532 / 202890 (2.7%) | −241.5 | −239.5 | 2.81 |
| STAT1 SRX2961562 | SET-2 Blood | 2033 / 20289 (10.0%) | 8494 / 202890 (4.2%) | −241.4 | −239.3 | 2.39 |
| BRD4 SRX1272808 | COLO 741 Digestive tract | 1674 / 20289 (8.3%) | 6243 / 202890 (3.1%) | −241.0 | −238.9 | 2.68 |
| Epitope tags SRX10657968 | NALM-6 Blood | 2460 / 20289 (12.1%) | 11368 / 202890 (5.6%) | −240.8 | −238.8 | 2.16 |
| KMT2A SRX8151119 | VDH-15 Others | 2431 / 20289 (12.0%) | 11180 / 202890 (5.5%) | −240.2 | −238.2 | 2.17 |
| KAT6B DRX411443 | 293 Kidney | 2689 / 20289 (13.3%) | 12990 / 202890 (6.4%) | −239.9 | −237.8 | 2.07 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 2124 / 20289 (10.5%) | 9121 / 202890 (4.5%) | −239.9 | −237.8 | 2.33 |
| GATA1 SRX4172742 | HCT 116 Digestive tract | 1863 / 20289 (9.2%) | 7434 / 202890 (3.7%) | −239.8 | −237.7 | 2.51 |
| KDM5A SRX23740430 | SUM 149PT Breast | 2123 / 20289 (10.5%) | 9115 / 202890 (4.5%) | −239.8 | −237.7 | 2.33 |
| BRD2 SRX6913056 | THP-1 Blood | 2027 / 20289 (10.0%) | 8496 / 202890 (4.2%) | −239.3 | −237.2 | 2.39 |
| BRD4 SRX13134686 | 293 Kidney | 1513 / 20289 (7.5%) | 5310 / 202890 (2.6%) | −239.0 | −236.9 | 2.85 |
| ETV6 SRX11661400 | EW-8 Bone | 2491 / 20289 (12.3%) | 11625 / 202890 (5.7%) | −238.9 | −236.8 | 2.14 |
| Epitope tags SRX10657966 | NALM-6 Blood | 2434 / 20289 (12.0%) | 11230 / 202890 (5.5%) | −238.8 | −236.8 | 2.17 |
| ZFX SRX3091909 | C4-2 Prostate | 1531 / 20289 (7.5%) | 5421 / 202890 (2.7%) | −238.6 | −236.6 | 2.82 |
| PHF8 SRX116437 | K-562 Blood | 2103 / 20289 (10.4%) | 9010 / 202890 (4.4%) | −238.4 | −236.3 | 2.33 |
| KMT2A SRX5732677 | MOLM-13 Blood | 1334 / 20289 (6.6%) | 4297 / 202890 (2.1%) | −238.2 | −236.1 | 3.10 |
| BCL11B SRX9867021 | DND-41 Blood | 1441 / 20289 (7.1%) | 4905 / 202890 (2.4%) | −238.1 | −236.1 | 2.94 |
| MECOM SRX23677891 | HNT-34 Blood | 2243 / 20289 (11.1%) | 9949 / 202890 (4.9%) | −238.0 | −235.9 | 2.25 |
| Epitope tags SRX10657967 | NALM-6 Blood | 2378 / 20289 (11.7%) | 10868 / 202890 (5.4%) | −237.8 | −235.8 | 2.19 |
| MECOM SRX23677890 | HNT-34 Blood | 2248 / 20289 (11.1%) | 10012 / 202890 (4.9%) | −236.6 | −234.6 | 2.25 |
| KDM5A SRX23740438 | SUM 149PT Breast | 2172 / 20289 (10.7%) | 9504 / 202890 (4.7%) | −236.5 | −234.5 | 2.29 |
| KAT6B DRX411444 | 293 Kidney | 2649 / 20289 (13.1%) | 12783 / 202890 (6.3%) | −236.5 | −234.4 | 2.07 |
| RUNX1T1 SRX8673361 | Kasumi-1 Blood | 1541 / 20289 (7.6%) | 5514 / 202890 (2.7%) | −236.3 | −234.2 | 2.79 |
| KMT2A SRX8151118 | VDH-15 Others | 2521 / 20289 (12.4%) | 11899 / 202890 (5.9%) | −235.9 | −233.9 | 2.12 |
| BCORL1 SRX10184498 | K-562 Blood | 2593 / 20289 (12.8%) | 12407 / 202890 (6.1%) | −235.8 | −233.7 | 2.09 |
| NELFA SRX10333914 | DLD-1 Digestive tract | 1690 / 20289 (8.3%) | 6429 / 202890 (3.2%) | −235.3 | −233.3 | 2.63 |
| KAT7 DRX300414 | 293 Kidney | 837 / 20289 (4.1%) | 1812 / 202890 (0.9%) | −234.9 | −232.9 | 4.62 |
| CNOT3 SRX886405 | HCT 116 Digestive tract | 2329 / 20289 (11.5%) | 10598 / 202890 (5.2%) | −234.8 | −232.8 | 2.20 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 573 / 20289 (2.8%) | 770 / 202890 (0.4%) | −234.6 | −232.6 | 7.44 |
| MYC SRX10338559 | NALM-6 Blood | 2619 / 20289 (12.9%) | 12622 / 202890 (6.2%) | −234.3 | −232.3 | 2.07 |
| ZFX SRX3321903 | C4-2 Prostate | 1552 / 20289 (7.6%) | 5610 / 202890 (2.8%) | −234.2 | −232.2 | 2.77 |
| KMT2A SRX8151116 | VDH-15 Others | 2149 / 20289 (10.6%) | 9405 / 202890 (4.6%) | −233.8 | −231.7 | 2.28 |
| KMT2A SRX5668140 | OCI-AML3 Blood | 786 / 20289 (3.9%) | 1599 / 202890 (0.8%) | −233.7 | −231.7 | 4.92 |
| MEAF6 SRX10606584 | GIST-T1 Digestive tract | 1934 / 20289 (9.5%) | 8001 / 202890 (3.9%) | −233.4 | −231.4 | 2.42 |
| YY1 SRX10774935 | DND-41 Blood | 2053 / 20289 (10.1%) | 8780 / 202890 (4.3%) | −233.2 | −231.1 | 2.34 |
| ETV6 SRX11661398 | EW-8 Bone | 2494 / 20289 (12.3%) | 11787 / 202890 (5.8%) | −232.5 | −230.5 | 2.12 |
| BCORL1 SRX10184497 | K-562 Blood | 2517 / 20289 (12.4%) | 11947 / 202890 (5.9%) | −232.5 | −230.5 | 2.11 |
| FOXA1 SRX176862 | MCF-7 Breast | 535 / 20289 (2.6%) | 16844 / 202890 (8.3%) | −231.8 | −229.8 | 0.32 |
| BCL11B SRX9867024 | TALL-1 Blood | 3131 / 20289 (15.4%) | 16421 / 202890 (8.1%) | −230.8 | −228.8 | 1.91 |
| AR SRX1067071 | LHSAR Prostate | 805 / 20289 (4.0%) | 21012 / 202890 (10.4%) | −230.5 | −228.5 | 0.38 |
| BAHCC1 SRX8449942 | Jurkat Blood | 3146 / 20289 (15.5%) | 16544 / 202890 (8.2%) | −230.4 | −228.4 | 1.90 |
| RAG1 SRX1898037 | REH Blood | 2675 / 20289 (13.2%) | 13143 / 202890 (6.5%) | −229.1 | −227.1 | 2.04 |
| FOXA1 SRX176863 | MCF-7 Breast | 492 / 20289 (2.4%) | 16013 / 202890 (7.9%) | −228.2 | −226.1 | 0.31 |
| ETV6 SRX11661401 | EW-8 Bone | 2544 / 20289 (12.5%) | 12240 / 202890 (6.0%) | −228.0 | −225.9 | 2.08 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 1420 / 20289 (7.0%) | 4926 / 202890 (2.4%) | −227.9 | −225.9 | 2.88 |
| KMT2A SRX15213706 | SEM Blood | 882 / 20289 (4.3%) | 2077 / 202890 (1.0%) | −227.8 | −225.8 | 4.25 |
| MEN1 SRX4046307 | Erythroblasts Blood | 1093 / 20289 (5.4%) | 3120 / 202890 (1.5%) | −227.8 | −225.8 | 3.50 |
| BRD4 SRX9071234 | SEM Blood | 1337 / 20289 (6.6%) | 4451 / 202890 (2.2%) | −227.7 | −225.7 | 3.00 |
| RUVBL2 SRX9424449 | GM12878 Blood | 2304 / 20289 (11.4%) | 10582 / 202890 (5.2%) | −227.5 | −225.5 | 2.18 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 1397 / 20289 (6.9%) | 29290 / 202890 (14.4%) | −227.4 | −225.4 | 0.48 |
| MED1 SRX13134690 | 293 Kidney | 1513 / 20289 (7.5%) | 5480 / 202890 (2.7%) | −227.4 | −225.4 | 2.76 |
| YAP1 SRX5718140 | 293 Kidney | 683 / 20289 (3.4%) | 19035 / 202890 (9.4%) | −227.3 | −225.3 | 0.36 |
| Epitope tags SRX11149778 | Jurkat Blood | 2731 / 20289 (13.5%) | 13590 / 202890 (6.7%) | −227.2 | −225.1 | 2.01 |
| MYC SRX1539275 | P493-6 Blood | 1410 / 20289 (6.9%) | 4878 / 202890 (2.4%) | −227.1 | −225.1 | 2.89 |
| KDM5A SRX23740439 | SUM 149PT Breast | 2106 / 20289 (10.4%) | 9250 / 202890 (4.6%) | −227.0 | −225.0 | 2.28 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 1006 / 20289 (5.0%) | 2684 / 202890 (1.3%) | −227.0 | −225.0 | 3.75 |
| KMT2A SRX8151117 | VDH-15 Others | 2597 / 20289 (12.8%) | 12640 / 202890 (6.2%) | −226.8 | −224.8 | 2.05 |
| ASUN SRX3990567 | Monocytes Blood | 1093 / 20289 (5.4%) | 3132 / 202890 (1.5%) | −226.7 | −224.7 | 3.49 |
| Epitope tags SRX15715083 | Jurkat Blood | 2268 / 20289 (11.2%) | 10352 / 202890 (5.1%) | −226.7 | −224.7 | 2.19 |
| ERG SRX026653 | CD34 Hematopoietic stem cells Blood | 1988 / 20289 (9.8%) | 8481 / 202890 (4.2%) | −226.4 | −224.4 | 2.34 |
| ZFX SRX7805372 | 293 Kidney | 1923 / 20289 (9.5%) | 8059 / 202890 (4.0%) | −226.3 | −224.3 | 2.39 |
| HDAC1 SRX17989499 | PBMC Blood | 2185 / 20289 (10.8%) | 9798 / 202890 (4.8%) | −226.3 | −224.3 | 2.23 |
| BRD4 SRX1287852 | MOLM-14 Blood | 2628 / 20289 (13.0%) | 12876 / 202890 (6.3%) | −226.2 | −224.2 | 2.04 |
| KMT2A SRX14127514 | OCI-AML3 Blood | 605 / 20289 (3.0%) | 928 / 202890 (0.5%) | −226.1 | −224.1 | 6.52 |
| RTF1 SRX15147196 | DLD-1 Digestive tract | 885 / 20289 (4.4%) | 2108 / 202890 (1.0%) | −225.9 | −223.9 | 4.20 |
| KAT6A DRX411442 | 293 Kidney | 2126 / 20289 (10.5%) | 9419 / 202890 (4.6%) | −225.4 | −223.4 | 2.26 |
| BRD4 SRX2166889 | Retina Neural | 1764 / 20289 (8.7%) | 7066 / 202890 (3.5%) | −224.9 | −222.9 | 2.50 |
| MECOM SRX23677896 | HNT-34 Blood | 2573 / 20289 (12.7%) | 12534 / 202890 (6.2%) | −224.2 | −222.2 | 2.05 |
| MEAF6 SRX10606586 | GIST-T1 Digestive tract | 1537 / 20289 (7.6%) | 5676 / 202890 (2.8%) | −224.0 | −222.0 | 2.71 |
| TP53 SRX19538282 | Osteoblasts Bone | 422 / 20289 (2.1%) | 357 / 202890 (0.2%) | −223.9 | −221.9 | 11.82 |
| TP53 SRX19538270 | U2OS Bone | 474 / 20289 (2.3%) | 503 / 202890 (0.2%) | −223.8 | −221.8 | 9.42 |
| BCL11B SRX9867025 | TALL-1 Blood | 3132 / 20289 (15.4%) | 16631 / 202890 (8.2%) | −223.2 | −221.2 | 1.88 |
| MED1 SRX13134691 | 293 Kidney | 1420 / 20289 (7.0%) | 4993 / 202890 (2.5%) | −223.2 | −221.2 | 2.84 |
| MECOM SRX23677897 | HNT-34 Blood | 2485 / 20289 (12.2%) | 11936 / 202890 (5.9%) | −223.2 | −221.2 | 2.08 |
| ZFX SRX3091902 | MCF-7 Breast | 1258 / 20289 (6.2%) | 4073 / 202890 (2.0%) | −222.6 | −220.6 | 3.09 |
| MYC SRX5346116 | RAMOS Blood | 1341 / 20289 (6.6%) | 4545 / 202890 (2.2%) | −222.5 | −220.5 | 2.95 |
| GFP SRX12567758 | MRC-5 Lung | 1869 / 20289 (9.2%) | 7786 / 202890 (3.8%) | −222.3 | −220.3 | 2.40 |
| SETD1A SRX7551119 | HeLa Uterus | 2075 / 20289 (10.2%) | 9141 / 202890 (4.5%) | −222.1 | −220.2 | 2.27 |
| PAF1 SRX15147186 | DLD-1 Digestive tract | 1032 / 20289 (5.1%) | 2871 / 202890 (1.4%) | −221.7 | −219.7 | 3.59 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 645 / 20289 (3.2%) | 1106 / 202890 (0.5%) | −221.5 | −219.5 | 5.83 |
| BMI1 SRX7196715 | SU-DIPG-IV Neural | 2188 / 20289 (10.8%) | 9923 / 202890 (4.9%) | −221.3 | −219.3 | 2.20 |
| SAP30 SRX17989897 | MDA-MB-231 Breast | 2363 / 20289 (11.6%) | 11129 / 202890 (5.5%) | −221.1 | −219.1 | 2.12 |
| 5-mC SRX882970 | LNCAP Prostate | 3314 / 20289 (16.3%) | 18064 / 202890 (8.9%) | −221.0 | −219.0 | 1.83 |
| BRD4 SRX17033751 | MOLM-13 Blood | 1388 / 20289 (6.8%) | 4839 / 202890 (2.4%) | −220.9 | −219.0 | 2.87 |
| MED26 SRX7061822 | SEM Blood | 1097 / 20289 (5.4%) | 3224 / 202890 (1.6%) | −220.4 | −218.4 | 3.40 |
| CTCF SRX10976010 | 697 Blood | 2435 / 20289 (12.0%) | 11651 / 202890 (5.7%) | −220.3 | −218.3 | 2.09 |
| STAT5B SRX831881 | CD8+ T cells Blood | 326 / 20289 (1.6%) | 149 / 202890 (0.1%) | −219.7 | −217.7 | 21.88 |
| EP300 SRX2671813 | Fibroblasts Others | 314 / 20289 (1.5%) | 12652 / 202890 (6.2%) | −219.1 | −217.2 | 0.25 |
| SUPT5H SRX2314265 | MOLT-4 Blood | 1799 / 20289 (8.9%) | 7390 / 202890 (3.6%) | −219.1 | −217.2 | 2.43 |
| TRIM25 SRX1660873 | Breast cancer cells Breast | 2321 / 20289 (11.4%) | 10886 / 202890 (5.4%) | −219.0 | −217.0 | 2.13 |
| ATF4 SRX10900660 | NALM-6 Blood | 1873 / 20289 (9.2%) | 7873 / 202890 (3.9%) | −218.8 | −216.8 | 2.38 |
| RUNX1 SRX23677918 | MOLM-14 Blood | 1117 / 20289 (5.5%) | 3349 / 202890 (1.7%) | −218.8 | −216.8 | 3.34 |
| FOXA1 SRX4815197 | MCF-7 Breast | 1032 / 20289 (5.1%) | 23889 / 202890 (11.8%) | −218.8 | −216.8 | 0.43 |
| AML1-ETO SRX4143076 | Kasumi-1 Blood | 3291 / 20289 (16.2%) | 17987 / 202890 (8.9%) | −217.6 | −215.7 | 1.83 |
| ESR1 SRX371469 | MCF-7 Breast | 437 / 20289 (2.2%) | 14747 / 202890 (7.3%) | −217.4 | −215.4 | 0.30 |
| GATA1 SRX4172743 | HCT 116 Digestive tract | 1898 / 20289 (9.4%) | 8069 / 202890 (4.0%) | −217.1 | −215.1 | 2.35 |
| ERG SRX026657 | Acute promyelocytic leukemia Blood | 2314 / 20289 (11.4%) | 10881 / 202890 (5.4%) | −217.0 | −215.0 | 2.13 |
| ZFX SRX3322014 | 293 Kidney | 1580 / 20289 (7.8%) | 6053 / 202890 (3.0%) | −216.9 | −214.9 | 2.61 |
| MLLT6 DRX059637 | 293 Kidney | 525 / 20289 (2.6%) | 696 / 202890 (0.3%) | −216.8 | −214.9 | 7.54 |
| ZFX SRX3091917 | 293 Kidney | 1562 / 20289 (7.7%) | 5942 / 202890 (2.9%) | −216.7 | −214.8 | 2.63 |
| ZFX SRX7805361 | 293 Kidney | 1562 / 20289 (7.7%) | 5942 / 202890 (2.9%) | −216.7 | −214.8 | 2.63 |
| ERG SRX4484988 | SEM Blood | 3900 / 20289 (19.2%) | 22739 / 202890 (11.2%) | −216.6 | −214.7 | 1.72 |
| ZFX SRX3322358 | MCF-7 Breast | 1249 / 20289 (6.2%) | 4101 / 202890 (2.0%) | −216.4 | −214.5 | 3.05 |
| AFF1 SRX2323906 | Pre-B cell leukemia Blood | 654 / 20289 (3.2%) | 1175 / 202890 (0.6%) | −216.3 | −214.3 | 5.57 |
| SUPT5H SRX7677724 | DLD-1 Digestive tract | 1938 / 20289 (9.6%) | 8362 / 202890 (4.1%) | −215.6 | −213.7 | 2.32 |
| NUTM1 SRX20497472 | 293 Kidney | 940 / 20289 (4.6%) | 2471 / 202890 (1.2%) | −215.5 | −213.6 | 3.80 |
| ZFX SRX7805370 | 293 Kidney | 1429 / 20289 (7.0%) | 5161 / 202890 (2.5%) | −215.4 | −213.5 | 2.77 |
| AFF1 SRX15203355 | Acute lymphoid leukemia Blood | 540 / 20289 (2.7%) | 756 / 202890 (0.4%) | −215.1 | −213.1 | 7.14 |
| ESR1 SRX371478 | MCF-7 Breast | 551 / 20289 (2.7%) | 16518 / 202890 (8.1%) | −214.5 | −212.6 | 0.33 |
| FOXA1 SRX4815198 | MCF-7 Breast | 1427 / 20289 (7.0%) | 29146 / 202890 (14.4%) | −214.1 | −212.1 | 0.49 |
| ATF4 SRX10900661 | NALM-6 Blood | 1965 / 20289 (9.7%) | 8572 / 202890 (4.2%) | −213.9 | −211.9 | 2.29 |
| RUVBL2 SRX9424448 | GM12878 Blood | 2142 / 20289 (10.6%) | 9768 / 202890 (4.8%) | −213.8 | −211.9 | 2.19 |
| GATA3 SRX190194 | SK-N-SH Neural | 1004 / 20289 (4.9%) | 23291 / 202890 (11.5%) | −213.6 | −211.7 | 0.43 |
| KDM5A SRX8053100 | MM.1S Blood | 1853 / 20289 (9.1%) | 7845 / 202890 (3.9%) | −213.5 | −211.6 | 2.36 |
| ETS1 SRX9046309 | THP-1 Blood | 900 / 20289 (4.4%) | 2303 / 202890 (1.1%) | −212.6 | −210.7 | 3.91 |
| 5-mC SRX882968 | LNCAP Prostate | 3265 / 20289 (16.1%) | 17937 / 202890 (8.8%) | −212.5 | −210.6 | 1.82 |
| ESR1 SRX371476 | MCF-7 Breast | 302 / 20289 (1.5%) | 12215 / 202890 (6.0%) | −211.9 | −210.0 | 0.25 |
| FOS SRX4192879 | MCF 10A Breast | 479 / 20289 (2.4%) | 15262 / 202890 (7.5%) | −211.9 | −209.9 | 0.31 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 958 / 20289 (4.7%) | 22563 / 202890 (11.1%) | −211.8 | −209.9 | 0.42 |
| KMT2A SRX14127516 | OCI-AML3 Blood | 609 / 20289 (3.0%) | 1028 / 202890 (0.5%) | −211.7 | −209.7 | 5.92 |
| BCOR SRX10184479 | K-562 Blood | 2627 / 20289 (12.9%) | 13228 / 202890 (6.5%) | −211.4 | −209.5 | 1.99 |
| BCOR SRX10184477 | K-562 Blood | 2558 / 20289 (12.6%) | 12733 / 202890 (6.3%) | −211.3 | −209.4 | 2.01 |
| NABP2 SRX9523535 | HT-1080 Bone | 1681 / 20289 (8.3%) | 6779 / 202890 (3.3%) | −211.2 | −209.3 | 2.48 |
| MEAF6 DRX300408 | HB1119 Blood | 607 / 20289 (3.0%) | 1025 / 202890 (0.5%) | −210.9 | −209.0 | 5.92 |
| BRD4 SRX849384 | MOLM-14 Blood | 956 / 20289 (4.7%) | 2603 / 202890 (1.3%) | −210.4 | −208.5 | 3.67 |
| NFYB SRX16608147 | HeLa Uterus | 342 / 20289 (1.7%) | 205 / 202890 (0.1%) | −209.9 | −208.0 | 16.68 |
| SUPT6H SRX15147169 | DLD-1 Digestive tract | 1366 / 20289 (6.7%) | 4886 / 202890 (2.4%) | −208.8 | −206.8 | 2.80 |
| BMI1 SRX7196721 | SF8628 Neural | 2040 / 20289 (10.1%) | 9185 / 202890 (4.5%) | −208.5 | −206.6 | 2.22 |
| RBM22 SRX10977334 | K-562 Blood | 767 / 20289 (3.8%) | 1715 / 202890 (0.8%) | −208.4 | −206.5 | 4.47 |
| STAT5A SRX9681372 | ARP-1 Blood | 1694 / 20289 (8.3%) | 6913 / 202890 (3.4%) | −208.4 | −206.5 | 2.45 |
| CTCF SRX10976009 | 697 Blood | 2786 / 20289 (13.7%) | 14472 / 202890 (7.1%) | −208.2 | −206.3 | 1.93 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 551 / 20289 (2.7%) | 832 / 202890 (0.4%) | −208.1 | −206.2 | 6.62 |
| BRD4 SRX1873449 | SEM Blood | 1097 / 20289 (5.4%) | 3369 / 202890 (1.7%) | −208.1 | −206.2 | 3.26 |
| Epitope tags SRX15725652 | 293 Kidney | 2219 / 20289 (10.9%) | 10423 / 202890 (5.1%) | −208.0 | −206.1 | 2.13 |
| BRD4 SRX1637463 | MOLT-4 Blood | 2579 / 20289 (12.7%) | 12969 / 202890 (6.4%) | −207.9 | −206.0 | 1.99 |
| SSRP1 SRX3436567 | HT-1080 Bone | 491 / 20289 (2.4%) | 626 / 202890 (0.3%) | −207.9 | −206.0 | 7.84 |
| Epitope tags SRX9742024 | HeLa Uterus | 1101 / 20289 (5.4%) | 3393 / 202890 (1.7%) | −207.9 | −206.0 | 3.24 |
| AR SRX1067070 | LHSAR Prostate | 1061 / 20289 (5.2%) | 23870 / 202890 (11.8%) | −207.8 | −205.8 | 0.44 |
| BRD4 SRX8002112 | SKM-1 Blood | 940 / 20289 (4.6%) | 2552 / 202890 (1.3%) | −207.6 | −205.7 | 3.68 |
| ERG SRX1514277 | Kasumi-1 Blood | 2512 / 20289 (12.4%) | 12500 / 202890 (6.2%) | −207.5 | −205.6 | 2.01 |
| ARID4B SRX16495793 | K-562 Blood | 1308 / 20289 (6.4%) | 4565 / 202890 (2.2%) | −207.3 | −205.4 | 2.87 |
| AFF1 SRX2323907 | Pre-B cell leukemia Blood | 597 / 20289 (2.9%) | 1011 / 202890 (0.5%) | −206.9 | −205.0 | 5.91 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 738 / 20289 (3.6%) | 1600 / 202890 (0.8%) | −206.6 | −204.7 | 4.61 |
| BRD4 SRX6913099 | CD4+ T cells Blood | 1626 / 20289 (8.0%) | 6514 / 202890 (3.2%) | −206.5 | −204.6 | 2.50 |
| USP7 SRX3433644 | CUTLL1 Blood | 2884 / 20289 (14.2%) | 15240 / 202890 (7.5%) | −206.5 | −204.6 | 1.89 |
| RUNX1T1 SRX8536089 | CD34+ Blood | 1683 / 20289 (8.3%) | 6876 / 202890 (3.4%) | −206.4 | −204.5 | 2.45 |
| MED12 SRX7061820 | SEM Blood | 2918 / 20289 (14.4%) | 15495 / 202890 (7.6%) | −206.4 | −204.5 | 1.88 |
| CXXC1 SRX4046314 | Lymphoblastoid cell line Blood | 811 / 20289 (4.0%) | 1937 / 202890 (1.0%) | −206.2 | −204.3 | 4.19 |
| NR3C1 SRX2609664 | HASM2 Lung | 592 / 20289 (2.9%) | 16882 / 202890 (8.3%) | −206.1 | −204.2 | 0.35 |
| KMT2A SRX8151121 | VDH-15 Others | 2564 / 20289 (12.6%) | 12910 / 202890 (6.4%) | −206.0 | −204.1 | 1.99 |
| BRD4 SRX10158160 | KBM-7 Blood | 1372 / 20289 (6.8%) | 4961 / 202890 (2.4%) | −206.0 | −204.1 | 2.77 |
| TAL1 SRX265227 | ME-1 Blood | 1018 / 20289 (5.0%) | 2973 / 202890 (1.5%) | −205.9 | −204.0 | 3.42 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 1444 / 20289 (7.1%) | 29022 / 202890 (14.3%) | −205.7 | −203.8 | 0.50 |
| CDK9 SRX7366783 | MCF-7 Breast | 306 / 20289 (1.5%) | 141 / 202890 (0.1%) | −205.7 | −203.8 | 21.70 |
| BRD7 SRX18945348 | 786-O Kidney | 1046 / 20289 (5.2%) | 3128 / 202890 (1.5%) | −205.3 | −203.4 | 3.34 |
| MAZ SRX20870814 | SEM Blood | 1609 / 20289 (7.9%) | 6430 / 202890 (3.2%) | −205.2 | −203.3 | 2.50 |
| CDYL2 SRX8321653 | MCF-7 Breast | 2163 / 20289 (10.7%) | 10106 / 202890 (5.0%) | −204.8 | −202.9 | 2.14 |
| CTCF SRX10976001 | NALM-6 Blood | 3053 / 20289 (15.0%) | 16556 / 202890 (8.2%) | −204.7 | −202.8 | 1.84 |
| IRF3 SRX11453858 | Hep G2 Liver | 291 / 20289 (1.4%) | 116 / 202890 (0.1%) | −204.3 | −202.4 | 25.09 |
| ZFX SRX3322751 | K-562 Blood | 1570 / 20289 (7.7%) | 6204 / 202890 (3.1%) | −204.0 | −202.1 | 2.53 |
| RUNX1 SRX063913 | SKNO-1 Blood | 2117 / 20289 (10.4%) | 9815 / 202890 (4.8%) | −203.6 | −201.8 | 2.16 |
| PBRM1 SRX8566576 | HK-2 Kidney | 1683 / 20289 (8.3%) | 6929 / 202890 (3.4%) | −203.6 | −201.7 | 2.43 |
| BRD4 SRX6913091 | K-562 Blood | 1802 / 20289 (8.9%) | 7701 / 202890 (3.8%) | −203.5 | −201.7 | 2.34 |
| KMT2A SRX4931251 | 293 Kidney | 1174 / 20289 (5.8%) | 3852 / 202890 (1.9%) | −203.5 | −201.6 | 3.05 |
| KMT2A SRX4931241 | 293 Kidney | 1463 / 20289 (7.2%) | 5553 / 202890 (2.7%) | −203.4 | −201.6 | 2.63 |
| BRD4 SRX1134763 | MV-4-11 Blood | 1650 / 20289 (8.1%) | 6723 / 202890 (3.3%) | −203.3 | −201.4 | 2.45 |
| ESR1 SRX176860 | MCF-7 Breast | 724 / 20289 (3.6%) | 18805 / 202890 (9.3%) | −203.2 | −201.3 | 0.39 |
| BRD4 SRX5213646 | HCC1937 Breast | 1309 / 20289 (6.5%) | 4640 / 202890 (2.3%) | −202.7 | −200.8 | 2.82 |
| FLI1 SRX1514276 | Kasumi-1 Blood | 1797 / 20289 (8.9%) | 7689 / 202890 (3.8%) | −202.4 | −200.5 | 2.34 |
| Epitope tags SRX15725650 | 293 Kidney | 1971 / 20289 (9.7%) | 8847 / 202890 (4.4%) | −202.3 | −200.4 | 2.23 |
| SS18 SRX3468047 | Fibroblasts Others | 1104 / 20289 (5.4%) | 24249 / 202890 (12.0%) | −202.1 | −200.3 | 0.46 |
| PTEN SRX5416007 | SMMC-7721 Liver | 2123 / 20289 (10.5%) | 9887 / 202890 (4.9%) | −202.1 | −200.2 | 2.15 |
| ZFY SRX7805367 | 22Rv1 Prostate | 1157 / 20289 (5.7%) | 3781 / 202890 (1.9%) | −201.6 | −199.8 | 3.06 |
| SUPT5H SRX11555383 | DLD-1 Digestive tract | 1926 / 20289 (9.5%) | 8562 / 202890 (4.2%) | −201.5 | −199.6 | 2.25 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 334 / 20289 (1.6%) | 12451 / 202890 (6.1%) | −201.1 | −199.2 | 0.27 |
| RUNX1T1 SRX1514278 | Kasumi-1 Blood | 1541 / 20289 (7.6%) | 6077 / 202890 (3.0%) | −200.9 | −199.0 | 2.54 |
| ZBTB26 SRX3322067 | 293 Kidney | 2299 / 20289 (11.3%) | 11146 / 202890 (5.5%) | −200.8 | −198.9 | 2.06 |
| RUNX1T1 SRX3098193 | Kasumi-1 Blood | 1102 / 20289 (5.4%) | 3487 / 202890 (1.7%) | −200.7 | −198.9 | 3.16 |
| MAX SRX5307507 | P493-6 Blood | 1240 / 20289 (6.1%) | 4268 / 202890 (2.1%) | −200.6 | −198.7 | 2.91 |
| CBFB SRX265218 | ME-1 Blood | 1778 / 20289 (8.8%) | 7602 / 202890 (3.7%) | −200.5 | −198.7 | 2.34 |
| CDK9 SRX20230574 | Ishikawa Uterus | 1799 / 20289 (8.9%) | 7741 / 202890 (3.8%) | −200.4 | −198.5 | 2.32 |
| BRD4 SRX369136 | CUTLL1 Blood | 1734 / 20289 (8.5%) | 7318 / 202890 (3.6%) | −200.2 | −198.4 | 2.37 |
| Epitope tags SRX11149779 | Jurkat Blood | 2425 / 20289 (12.0%) | 12060 / 202890 (5.9%) | −200.0 | −198.2 | 2.01 |
| RUNX1T1 SRX3098195 | Kasumi-1 Blood | 1163 / 20289 (5.7%) | 3837 / 202890 (1.9%) | −200.0 | −198.1 | 3.03 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 293 / 20289 (1.4%) | 129 / 202890 (0.1%) | −199.8 | −197.9 | 22.71 |
| ESR1 SRX4367193 | MCF-7 Breast | 1418 / 20289 (7.0%) | 28414 / 202890 (14.0%) | −199.5 | −197.6 | 0.50 |
| FOS SRX150476 | MCF 10A Breast | 774 / 20289 (3.8%) | 19407 / 202890 (9.6%) | −199.3 | −197.4 | 0.40 |
| FOXA1 SRX1161177 | MCF-7 Breast | 461 / 20289 (2.3%) | 14538 / 202890 (7.2%) | −198.9 | −197.1 | 0.32 |
| ETV6 SRX11661387 | A-673 Bone | 2794 / 20289 (13.8%) | 14781 / 202890 (7.3%) | −198.8 | −197.0 | 1.89 |
| ZFX SRX3322752 | K-562 Blood | 1329 / 20289 (6.6%) | 4818 / 202890 (2.4%) | −198.5 | −196.7 | 2.76 |
| BRD4 SRX9730740 | THP-1 Blood | 2818 / 20289 (13.9%) | 14975 / 202890 (7.4%) | −198.3 | −196.5 | 1.88 |
| ZNF711 SRX7805369 | 22Rv1 Prostate | 977 / 20289 (4.8%) | 2846 / 202890 (1.4%) | −198.1 | −196.2 | 3.43 |
| NR3C1 SRX2609665 | HASM2 Lung | 474 / 20289 (2.3%) | 14719 / 202890 (7.3%) | −198.0 | −196.2 | 0.32 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 741 / 20289 (3.7%) | 1690 / 202890 (0.8%) | −197.3 | −195.5 | 4.38 |
| ESR1 SRX20282961 | MCF-7 Breast | 575 / 20289 (2.8%) | 16296 / 202890 (8.0%) | −197.0 | −195.2 | 0.35 |
| CREBBP SRX359409 | 293 Kidney | 1898 / 20289 (9.4%) | 8472 / 202890 (4.2%) | −196.7 | −194.9 | 2.24 |
| BRD4 SRX6913088 | K-562 Blood | 2139 / 20289 (10.5%) | 10122 / 202890 (5.0%) | −196.6 | −194.8 | 2.11 |
| ETV6 SRX11661386 | A-673 Bone | 2771 / 20289 (13.7%) | 14673 / 202890 (7.2%) | −196.5 | −194.7 | 1.89 |
| JUNB SRX8488088 | SUM 229PE Breast | 871 / 20289 (4.3%) | 20719 / 202890 (10.2%) | −196.4 | −194.6 | 0.42 |
| CHD1 SRX116454 | hESC H1 Pluripotent stem cell | 995 / 20289 (4.9%) | 2961 / 202890 (1.5%) | −196.3 | −194.5 | 3.36 |
| DNA-RNA hybrid SRX20083261 | SH-SY5Y Neural | 715 / 20289 (3.5%) | 1582 / 202890 (0.8%) | −196.2 | −194.3 | 4.52 |
| CBFB SRX265219 | ME-1 Blood | 1302 / 20289 (6.4%) | 4693 / 202890 (2.3%) | −196.2 | −194.3 | 2.77 |
| SREBF2 SRX5359048 | HCC70 Breast | 1967 / 20289 (9.7%) | 8957 / 202890 (4.4%) | −195.8 | −194.0 | 2.20 |
| Epitope tags SRX16749709 | SYO-1 Others | 1314 / 20289 (6.5%) | 4772 / 202890 (2.4%) | −195.8 | −193.9 | 2.75 |
| ELF1 SRX265229 | ME-1 Blood | 1188 / 20289 (5.9%) | 4039 / 202890 (2.0%) | −195.5 | −193.7 | 2.94 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 645 / 20289 (3.2%) | 17323 / 202890 (8.5%) | −195.4 | −193.6 | 0.37 |
| ETV6 SRX11661389 | A-673 Bone | 2761 / 20289 (13.6%) | 14633 / 202890 (7.2%) | −195.2 | −193.4 | 1.89 |
| ESR1 SRX176861 | MCF-7 Breast | 746 / 20289 (3.7%) | 18835 / 202890 (9.3%) | −195.1 | −193.2 | 0.40 |
| Epitope tags SRX9034608 | VCaP Prostate | 2414 / 20289 (11.9%) | 12105 / 202890 (6.0%) | −194.9 | −193.1 | 1.99 |
| KMT2A SRX1293532 | MV-4-11 Blood | 537 / 20289 (2.6%) | 857 / 202890 (0.4%) | −194.7 | −192.9 | 6.27 |
| 5-mC SRX882965 | LNCAP Prostate | 2663 / 20289 (13.1%) | 13932 / 202890 (6.9%) | −194.5 | −192.6 | 1.91 |
| RUNX1 SRX1036365 | Peripheral blood stem cells Blood | 1694 / 20289 (8.3%) | 7170 / 202890 (3.5%) | −194.3 | −192.5 | 2.36 |
| GATA3 SRX176864 | MCF-7 Breast | 319 / 20289 (1.6%) | 11975 / 202890 (5.9%) | −194.3 | −192.5 | 0.27 |
| FOXA1 SRX3931044 | MCF-7 Breast | 971 / 20289 (4.8%) | 22061 / 202890 (10.9%) | −194.0 | −192.2 | 0.44 |
| FOXA1 SRX1161173 | MCF-7 Breast | 363 / 20289 (1.8%) | 12729 / 202890 (6.3%) | −194.0 | −192.2 | 0.29 |
| SUPT5H SRX11555382 | DLD-1 Digestive tract | 2000 / 20289 (9.9%) | 9233 / 202890 (4.6%) | −193.5 | −191.7 | 2.17 |
| RUNX1 SRX669872 | Acute myeloid leukemia Blood | 1693 / 20289 (8.3%) | 7182 / 202890 (3.5%) | −193.5 | −191.6 | 2.36 |
| Epitope tags SRX11149772 | Jurkat Blood | 2818 / 20289 (13.9%) | 15110 / 202890 (7.4%) | −193.5 | −191.6 | 1.86 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 529 / 20289 (2.6%) | 15448 / 202890 (7.6%) | −193.4 | −191.6 | 0.34 |
| MYC SRX10338564 | NALM-6 Blood | 1840 / 20289 (9.1%) | 8155 / 202890 (4.0%) | −193.3 | −191.5 | 2.26 |
| MITF SRX1555436 | 501A Epidermis | 2272 / 20289 (11.2%) | 11134 / 202890 (5.5%) | −193.3 | −191.4 | 2.04 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 1064 / 20289 (5.2%) | 23333 / 202890 (11.5%) | −193.1 | −191.3 | 0.46 |
| NR3C1 SRX2609662 | HASM2 Lung | 526 / 20289 (2.6%) | 15381 / 202890 (7.6%) | −192.9 | −191.0 | 0.34 |
| WDR5 SRX5416008 | SMMC-7721 Liver | 2094 / 20289 (10.3%) | 9895 / 202890 (4.9%) | −192.8 | −191.0 | 2.12 |
| BRD4 SRX13134685 | 293 Kidney | 1526 / 20289 (7.5%) | 6125 / 202890 (3.0%) | −192.7 | −190.8 | 2.49 |
| MYCN SRX9821833 | SH-EP Neural | 1600 / 20289 (7.9%) | 6599 / 202890 (3.3%) | −192.3 | −190.5 | 2.42 |
Showing first 500 of 25910 rows.